Press Releases and Product Information December 14, 2022
advertisement
- Dexcom finally ties up long-awaited G7 diabetes sensor clearance after FDA resubmission
- Phase III trial demonstrated Jardiance® is the first SGLT2 inhibitor to show statistically significant reduction in blood sugar levels in children and adolescents with type 2 diabetes
- One Drop Gives Back to Diabetes Community with Donation to Insulin for Life USA
- FDA clears Mallya smart insulin pen device from Biocorp
- Eli Lilly discontinues Ypsomed collaboration to pursue its own U.S. insulin pump offering
- Dexcom partners with Green Shield, Health Depot on digital diabetes management service
- Health Canada licenses Medtronic extended-wear infusion set for insulin delivery
- CONTROL-IQ TECHNOLOGY Predicts and helps prevent highs and lows
- Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical